Search Results for ''

published presentations and documents on DocSlides.

Risk Factor Modification Post Stroke
Risk Factor Modification Post Stroke
by olivia-moreira
Ron Pellegrino, MD. November 20, 2015. Objectives...
REATMENT ALGORITHMS
REATMENT ALGORITHMS
by melody
People with diabetes have a 2 to 4 fold higher ris...
Randomized Comparison Duration Antiplatelet Therapy Implantation
Randomized Comparison Duration Antiplatelet Therapy Implantation
by theodore319
Hyeon-Cheol . Gwon. , . Joo. Yong Hahn, Young Bin...
Dual Anti-Platelet Therapy After TAVR?
Dual Anti-Platelet Therapy After TAVR?
by salem
By: Cole Smith PharmD Candidate 2021. University o...
Anti-platelet drugs Dr.
Anti-platelet drugs Dr.
by jaena
Ishfaq. . Bukhari. Dec. 2012. In healthy vascul...
Switching from dual antiplatelet therapy with aspirin plus a P2Y
Switching from dual antiplatelet therapy with aspirin plus a P2Y
by brown
12. inhibitor to dual pathway inhibition with asp...
COMPASS: Show Us the Way for Medical Management of PAD
COMPASS: Show Us the Way for Medical Management of PAD
by miller
Clinical Associate Professor of Medicine. SSM Heal...
Sumith   Aleti , MD, MPH, FACC
Sumith Aleti , MD, MPH, FACC
by dorothy
OHHI Cardiology Group. Antiplatelet and Anticoagul...
Cangrelor : Friend or Foe? -
Cangrelor : Friend or Foe? -
by ariel
Cangrelor. : Not the CHAMPION We Hoped For. James ...
TAVI with atrial fibrillation
TAVI with atrial fibrillation
by kittie-lecroy
TAVI with atrial fibrillation : which antithro...
DUAL ANTIPLATELET THERAPY
DUAL ANTIPLATELET THERAPY
by mary
(DAPT) . BHAVI SHAH, DNP, APRN, ANP-C. UNIVERSITY ...
Peng  Yin 1 , Andrea  L Jorgensen
Peng Yin 1 , Andrea L Jorgensen
by ani
1. , Andrew . P Morris. 1. , Richard Turner. 2. , ...
Randomized Open Label
Randomized Open Label
by roberts
A MulticenterStudy of Oral Anticoagulationwith or ...
SYNTHELABO VS ZAFA PHARMACEUTICAL LABORATORIES
SYNTHELABO VS ZAFA PHARMACEUTICAL LABORATORIES
by fauna
SANOFI-PRIVATE LIMITED SINDH HIGH COURT Suit No367...
ANTIAGREGANTES  PLAQUETARIOS
ANTIAGREGANTES PLAQUETARIOS
by fullyshro
AAS. Cairn. e . cols. (1985):. AAS vs . sulfinp...
ANTIPLATELET DRUGS Activation of platelets is considered an essential process for arterial thrombos
ANTIPLATELET DRUGS Activation of platelets is considered an essential process for arterial thrombos
by vestibulephilips
Physiologically; when platelets are activated, the...
 Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
by tatiana-dople
www.onlinecjc.com. ). .  . If your reuse request...